MedTrace Logo

A Study Using Breath Tests to Identify Patients at Risk for Gestational Diabetes

NCT07347262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-01-16

No results posted yet for this study

Summary

The aim of our study is to evaluate the feasibility, and diagnostic value of oral 13C labelled glucose breath test compared to the GCT and OGTT tests.

Conditions

  • Gestational Diabetes

Interventions

DIAGNOSTIC_TEST

Noninvasive Breath Test in Order to Identify Patients at Risk for Developing Gestational Diabetes

After a short explanation on how to use the kit participants will be asked to sample their breath every 15 minutes starting 30 minutes before the ingestion of glucose and ending six hours after the ingestion.

Sponsors & Collaborators

  • University of Galway

    collaborator OTHER

  • Kaplan Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-18
Primary Completion
2024-06-20
Completion
2024-06-20

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07347262 on ClinicalTrials.gov